IASLC Global Survey on Molecular Testing in Lung Cancer
IASLC Global Survey for Pathologists on Immune Biomarkers in Lung Cancer
Don’t miss this important opportunity to spend a few moments towards an effort to improve PD-L1 testing practice globally and for a chance to win free IASLC membership! As part of a project aiming to gain more information about the prevalence and practices of PD-L1 testing in lung cancer patients throughout the world, we invite pathologists to take this survey. Your participation is very important! Your answers will help us understand the current status of PD-L1 testing in lung cancer and improve the PD-L1 testing practice globally.
IASLC Lung Cancer News - Readership Survey
Does the IASLC Lung Cancer News provide nuanced commentary vital to your knowledge base? Is your specialty in thoracic oncology well represented?
Survey Response Page
DENVER – A cross-sectional survey showed a quarter of patients with detected incidental pulmonary nodules experienced significant distress related to the nodule. Detailed clinician communication increased patient knowledge, relieved distress, and improved patient experience.